Patients and drug makers target 'fail first' prescription model

Aug. 12, 2025 - New Yorkers prescribed expensive, name-brand drugs may have to try cheaper alternatives before they get what the doctor ordered, as the result of insurance practices. We discuss how this process could be more transparent and have stricter rules with Ashira Vantrees, director of legal strategy and advocacy at Aimed Alliance.ESCUCHAR RADIO 👉https://widget.spreaker.com/player?episode_id=70730354&theme=light&playlist=show&playlist-continuous=true&chapters-image=true&episode_image_position=right&hide-logo=true&hide-likes=true&hide-comments=true&hide-sharing=true&hide-download=false&cover_image_url=https%3A%2F%2Fd3wo5wojvuv7l.cloudfront.net%2Fimages.spreaker.com%2Foriginal%2F28309762a15caddc03af1f60293a7f2d.jpg&color=eb144c%22%20width=%2210